TAF1 intellectual disability syndrome is an X-linked disorder caused by loss-of-function mutations in the TAF1 gene. How these mutations cause dysmorphology, hypotonia, intellectual and motor defects is unknown. Mouse models which have embryonically targeted TAF1 have failed, possibly due to TAF1 being essential for viability, preferentially expressed in early brain development, and intolerant of mutation. Novel animal models are valuable tools for understanding neuronal pathology. Here, we report the development and characterization of a novel animal model for TAF1 ID syndrome in which the TAF1 gene is deleted in embryonic rats using clustered regularly interspaced short palindromic repeats (CRISPR) associated protein 9 (Cas9) technology and somatic brain transgenesis mediated by lentiviral transduction. Rat pups, post-natal day 3, were subjected to intracerebroventricular (ICV) injection of either gRNA-control or gRNA-TAF1 vectors. Rats were subjected to a battery of behavioral tests followed by histopathological analyses of brains at post-natal day 14 and day 35. TAF1-edited rats exhibited behavioral deficits at both the neonatal and juvenile stages of development. Deletion of TAF1 lead to a hypoplasia and loss of the Purkinje cells. Abnormal motor symptoms in TAF1-edited rats were associated with irregular cerebellar output caused by changes in the intrinsic activity of the Purkinje cells. Immunostaining revealed a reduction in the expression of the CaV3.1 T-type calcium channel.
Introduction
Mutations in TATA-box binding protein factor 1 (TAF1) protein are associated with a X-linked TAF1 intellectual disability (ID) syndrome (MIM: 300966) (2, 3) . Occurring in males, TAF1 ID syndrome presents with abnormalities in global developmental (motor, cognitive, and speech), hypotonia, gait abnormalities, and cerebellar hypoplasia (2, 3) . Exactly how mutations in TAF1 give rise to these neurological deficits remain unclear and there are no effect treatments for this disorder. Because TAF1 appears to serve as a scaffold on which TAF binding proteins and other TAFs interact in the assembly of transcription factor TFIID (4, 5) , it is not known how the many functions of this protein complex are linked to the development of TAF1 ID syndrome Before therapeutic options for the treatment of TAF ID syndrome can be evaluated, an animal model for this disease needs to be developed. Thus, recapitulating major clinical features and disease progression reported in TAF1 ID patients would be beneficial.
We hypothesized that deletion of TAF1 by CRISPR/Cas9 editing, into the maturing brain during the post-natal days (6-8) using a lentiviral vector might replicate TAF1 ID symptoms. This mode of administration allows the vector diffusion and infection to occur before maturation of axon myelination and gliogenesis -two processes that restrict free diffusion in the brain as well as infection of the maturing cerebellum. Similar approaches have been utilized to develop a rat model of synucleinopathy (9) and dystonia DYT1 (10) . We found that in neonatal rat pups, removal of TAF1 by CRISPR/Cas9 editing, results in defects in neonatal motor functions. Furthermore, the motor deficits were associated with loss of Purkinje cells in the cerebellum; the remaining Purkinje cells displayed abnormal firing frequencies. In addition, the motor defects persisted in TAF1-edited juvenile pups and were associated with morphologic abnormalities within the cerebellum.
Results

Design of CRISPR/Cas9 strategy for TAF1 gene editing in the CNS
We designed a clustered regularly interspaced short palindromic repeats (CRISPR) associated protein-9 nuclease (Cas9) approach to induce a double stranded break in the promoter region of the TAF1 gene (Fig. 1A) , which would lead to reduced expression of TAF1 protein. The primary reasons for selecting this region of the gene is that patients with TAF1 variants present with loss of function abnormalities (2, 3) . Lentiviral particles were generated and were injected intracerebroventricularly (ICV) into the brain of neonatal rats. Injection sites were verified with Evans blue dye (Fig. S1 ). Red fluorescent protein (RFP) staining indicated that cells within the cerebellum including Purkinje cells were transduced but not naïve animals ( Fig. 1B i-iii) . Using an antibody specific for TAF1, we detected efficient genome editing of the TAF1 gene resulting in reduced TAF1 protein expression (Fig. 1C i-iii) .
CRISPR/Cas9-mediated TAF1 deletion cause TAF1 ID-like motor deficits
Motor dysfunction is a characteristic of TAF 1D syndrome (2, 3) . Therefore, we performed a battery of neonatal motor tests to ascertain possible motor deficits between TAF-edited rat pups and control animals ( Fig. 1D) . Negative geotaxis refers to the orienting response and movement expressed in opposition to cues of a gravitational vector (11) . We observed that TAF1-edited pups displayed increased latency time in correcting their position relative to controls ( Fig. 2A) . The righting reflex evaluates the motor ability for a rat pup to flip onto its feet from a supine position (11) . Similar to the negative geotaxis test, TAF1-edited pups showed an increased latency time to "right" their position (Fig.   2B) . The tail suspension test is commonly used to measure stress and can also be used to assess motor alterations (i.e. motor coordination). In the tail suspension, the naïve and gRNA-control animals held their hind limbs wide apart from PD5 to PD13, whereas the TAF1-edited rats exhibited abnormal hindlimb clasping after PD7 (Fig. 2C) . The hind-limb suspension test assesses the proximal hind limb muscle strength, weakness, and fatigue in the animal. The hind-limb suspension test also evaluates general neuromuscular function, body muscle strength, and posture. It is designed specifically for neonates and can be used on animals PD 2-14 (12) . TAF1-edited rat pups showed hind-limb weakness as demonstrated by a marked decrease in hanging score compared to control animals (i.e. gRNA-control and naïve rat pups at the same age) (Fig. 2D) . Crawling is a behavior developed early in rodent pups between postnatal day (PD) 0-5, at which point pups start to transition to walking from 5-10 days old (11) . Thus, the ambulation test takes advantage of this transitional time course. We noted significant differences in ambulation, at PD 14, between the TAF1-edited rat pups compared to gRNA-control and untreated (naïve) rat pups (Fig. 2E) . Collectively, these data indicate motor dysfunction in CRISPR/Cas9-TAF1-edited treated rat pups.
We continued our behavioral assessment past the weanling stage. We performed the beam walking test and Open field test. The beam walking test can evaluate motor coordination and balance (13) . The beam crossing time (Fig. 3A) and number of foot slips errors were higher in the TAF1-edited animals at PD35 compared to controls (Fig. 3B) . In the open field test, TAF1-edited animals displayed a higher level of anxiety as inferred from increased grooming frequency (Fig. 3C) . Thus, TAF1-editing produces behavioral defects that appear to persist into the juvenile animals.
TAF1 deletion leads to cerebellar abnormalities
To examine a possible cellular basis for the behavioral defects, next we evaluated the morphology of the Purkinje cells by Hematoxylin and eosin (H&E) and Nissl staining. Our histopathology analysis showed that the architecture of the Purkinje cell layer was abnormal in TAF1-edited animals. In addition, the histopathology showed Purkinje cells were markedly hypoplastic in TAF1 treated animals relative to
controls (Fig. 4A and 4B i-iii).
Purkinje cells are characteristically Calbindin positive and the protein is abundant in the cell body axon and dendritic tree of the naïve and gRNA-control animals, however some of the Purkinje cells in the TAF1-edited animals did not stain as positive as the control group animals. (Fig. 4C i- 
iii).
We also observed a decrease in the number of Calbindin positive Purkinje cell in TAF1-edited animals compared to control animals ( Fig. D) . We conclude that organization of the Purkinje cell layer and morphology of Purkinje cell are altered during postnatal development in TAF1-edited rats.
CRISPR/Cas9-mediated TAF1 deletion leads to Purkinje cells excitatory neurotransmission abnormalities
To examine a possible functional basis for the behavioral defects, we next performed synaptic recordings of neurons in the Purkinje cell layer region of cerebellar slices (Fig. 5A ) using whole-cell patch clamp, specifically measuring spontaneous excitatory postsynaptic currents (sEPSCs) (Fig. 5B ).
There was no change in amplitude of sEPSCs between three groups ( Fig. 5B-D) . However, the frequency of sEPSCs was significantly decreased with TAF1-editing, compared with naïve or gRNAcontrol editing, respectively (Fig. 5F) Purkinje cell slices from both naïve animals and gRNA-control injected animals, whereas CaV3.1 expression was markedly reduced in TAF1-edited animals at post-natal day 14 (data not shown) and at post-natal day 35 (Fig. 6A ).
Discussion
Mutations in TAF1, which is a component of the TFIID transcription factor complex, are implicated in an X-linked genetic syndrome that afflicts males (3). Some of the clinical features associated with TAF1 ID syndrome include: delayed gross motor development, hypoplasia of the cerebellar vermis, and hypotonia (2, 3) . By deleting the TAF1 gene in postnatal rats, we generated an animal model that replicates the clinical features of TAF1 ID syndrome. We observed motor deficits in both young rats and juveniles, morphological changes and a loss in Purkinje cells in the TAF1-edited animals. As in humans,
we noted hypoplasia of the cerebellum, a pathological hallmark of dysfunction in TAF1 ID syndrome.
Our model underscores the relevance of the cerebellum to this neurodegenerative disease and offers a powerful platform for examination of the cellular and molecular pathways underpinning TAF1 ID syndrome.
Our model of TAF1 ID allowed us to explore how cerebellar dysfunction contributes to disease.
Two different pathways, parallel fibers (PF) from granule cells (GC) and climbing fibers (CF) from the cells in the inferior olive (I.O), project excitatory synaptic input to Purkinje cells (PC) (19) . PCs integrate these excitatory inputs and then send inhibitory GABAergic projections to the deep cerebellar nuclei (DCN) (20) . We found that, in Purkinje cells, the frequency of sEPSCs was significantly decreased with TAF1-editing, compared with naïve or control CRISPR respectively. These results are suggestive of presynaptic suppression of TAF1-editing on glutamate transmission of cerebellar Purkinje cells, which might lead to disinhibition of PCs and the alterations in ongoing motor activity and fine motor control.
We found that the organization of Purkinje cell layer and morphology of Purkinje cell are altered during postnatal development in TAF1-edited rats, we infer that the decrease of frequency of sEPSCs might result from the collapse of the cerebellar circuit.
T-type calcium channels are low voltage-activated calcium channels that transiently open to evoke tiny Ca 2+ currents (reviewed in (15)). T-type calcium channels regulate calcium influx from the extracellular region by opening the calcium channel (21), or activating calcium-induced calcium release from the internal calcium source (22, 23) . These results suggest a critical role for T-type calcium channels in regulating intracellular calcium homeostasis and maintaining cellular function (21, 24, 25) .
CaV3.1 T-type channels are abundant at the cerebellar synapse between parallel fibers and Purkinje cells where they contribute to synaptic depolarization (26) . Consistent with our previous in vitro findings (2), we observed a decrease in CaV3.1 expression in Purkinje cells in the present study. Because CaV3.1 appears to be required for neuroprogenitor cell viability and the primary pathway by which Ca2+ enters into cerebellar neurons (26, 27) , our results suggests that dyregulated calcium signaling, due to decreased CaV3.1 protein levels caused by TAF1 gene knockout, could be important in the pathogenesis of TAF1 ID syndrome.
In order for a gene to be transcribed, a transcriptional preinitiation complex (PIC) needs to assemble at its promoter. The first complex to bind the promoter is the general transcription factor, TFIID, consisting of the TATA-binding protein (TBP) and 13 different TBP-associated factors (TAFs) (5, 28) . Mutations in several other human TFIID subunit coding genes (i.e. TBP, TAF2, TAF6, TAF8, and TAF13) have been implicated in human diseases including many with neurological outcomes and intellectual disability (29-33). The outcome of these mutations on TAFs has not been assessed in detail, due in part to the lack of the development of animal models for these disorders of transcription regulation as disruption of TFIID subunits can be embryonic lethal (32, 34). Our facile approach for assessing TAF1 function in vivo, using CRISPR/Cas9-based gene editing coupled lentiviral transduction, could be applied to these disorders of transcription regulation and provide insight into underlying mechanisms of disease. Although our work did not achieve germline deletion of TAF1, the approach used here provides an instructive example of how spatially and temporally restricted deletion may be sufficient to mimic hallmarks of these neurological disorders.
In conclusion, the present study shows that targeted knockdown of TAF1 can be achieved in the brain of rats with postnatal delivery of a CRISPR-Cas9 lentiviral vector. The current results demonstrate that this approach led to motor defects and morphological abnormalities within the cerebellum reminiscent of the human neurological disease-TAF1 ID syndrome. This model therefore provides an interesting opportunity for further studies investigating the effects of aberrant TAF1 on neuronal dysfunction and paves the way for testing of possible therapeutic strategies to treat TAF1 ID syndrome.
Materials and Methods
Detailed descriptions of methods used, and any associated references are available in SI Materials and
Methods. Briefly, all biochemical, electrophysiology and behavior experiments were performed in a 
